- Home
- ELDN vs SLND Comparison
ELDN vs SLND Comparison
Compare ELDN & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- SLND
- Stock Information
- Founded
- ELDN 2004
- SLND 1900
- Country
- ELDN United States
- SLND United States
- Employees
- ELDN N/A
- SLND N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- SLND Military/Government/Technical
- Sector
- ELDN Health Care
- SLND Industrials
- Exchange
- ELDN Nasdaq
- SLND Nasdaq
- Market Cap
- ELDN 140.3M
- SLND 160.7M
- IPO Year
- ELDN N/A
- SLND N/A
- Fundamental
- Price
- ELDN $4.07
- SLND $3.05
- Analyst Decision
- ELDN Strong Buy
- SLND Buy
- Analyst Count
- ELDN 1
- SLND 2
- Target Price
- ELDN $16.00
- SLND $5.50
- AVG Volume (30 Days)
- ELDN 1.0M
- SLND 100.0K
- Earning Date
- ELDN 11-12-2024
- SLND 11-12-2024
- Dividend Yield
- ELDN N/A
- SLND N/A
- EPS Growth
- ELDN N/A
- SLND N/A
- EPS
- ELDN N/A
- SLND N/A
- Revenue
- ELDN N/A
- SLND $1,029,117,999.00
- Revenue This Year
- ELDN N/A
- SLND $0.91
- Revenue Next Year
- ELDN N/A
- SLND $5.38
- P/E Ratio
- ELDN N/A
- SLND N/A
- Revenue Growth
- ELDN N/A
- SLND N/A
- 52 Week Low
- ELDN $1.11
- SLND $1.85
- 52 Week High
- ELDN $5.54
- SLND $6.16
- Technical
- Relative Strength Index (RSI)
- ELDN 51.95
- SLND 46.59
- Support Level
- ELDN $3.76
- SLND $2.83
- Resistance Level
- ELDN $4.17
- SLND $3.00
- Average True Range (ATR)
- ELDN 0.39
- SLND 0.36
- MACD
- ELDN -0.15
- SLND 0.03
- Stochastic Oscillator
- ELDN 18.45
- SLND 64.16
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.